Detailed Information on Publication Record
2021
NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses
TIDU, Federico, Marco DE ZUANI, Shyam Sushama JOSE, Kamila BENDICKOVA, Lukáš KUBALA et. al.Basic information
Original name
NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses
Authors
TIDU, Federico (380 Italy, belonging to the institution), Marco DE ZUANI, Shyam Sushama JOSE (203 Czech Republic), Kamila BENDICKOVA (203 Czech Republic), Lukáš KUBALA (203 Czech Republic), Frank CARUSO, Francesca CAVALIERI, Giancarlo FORTE (380 Italy) and Jan FRIČ (203 Czech Republic, guarantor)
Edition
iSCIENCE, CAMBRIDGE, CELL PRESS, 2021, 2589-0042
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10700 1.7 Other natural sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.107
RIV identification code
RIV/00216224:14110/21:00122134
Organization unit
Faculty of Medicine
UT WoS
000667301700118
Keywords in English
NFAT signaling; human mesenchymal stromal cells
Tags
International impact, Reviewed
Změněno: 25/3/2022 09:14, Mgr. Tereza Miškechová
Abstract
V originále
Mesenchymal stromal cells (MSCs) combined with calcineurin-nuclear factor of activated T cell (CN-NFAT) inhibitors are being tested as a treatment for graft-versus-host disease (GvHD). The immunosuppressive properties of MSCs seem beneficial; however, their response during fungal infection, which is an important cause of mortality in patients with GvHD, is unknown. We report that MSCs phagocytose the fungal component zymosan, resulting in phosphorylation of spleen tyrosine kinase (Syk), increase in cytosolic calcium levels, and ultimately, increase in NFAT1 nuclear translocation. RNA sequencing analysis of zymosan-treated MSCs showed that CN-NFAT inhibition affects extracellular matrix (ECM) genes but not cytokine expression that is under the control of the NF-kappa B pathway. When coculturing MSCs or decellularized MSC-ECM with human peripheral blood mononuclear cells (PBMCs), selective NFAT inhibition in MSCs decreased cytokine expression by PBMCs. These findings reveal a dual mechanism underlying the MSC response to zymosan: while NF-kappa B directly controls inflammatory cytokine expression, NFAT impacts immune-cell functions by regulating ECM remodeling.
Links
LM2015091, research and development project |
|